Evaluation of Efficacy, Safety and Tolerability of a Combination of Clobetasol, Neomycin and Miconazole Versus Betamethasone, Clotrimazole and Neomycin Versus Betamethasone, Gentamycin and Miconazole in Subjects with Eczematous Disorders Associated with underlying Tinea or Yeast Infections.
dc.contributor.author | Shroff, Hasmukh Jayantilal | |
dc.date.accessioned | 2015-04-20T10:45:06Z | |
dc.date.available | 2015-04-20T10:45:06Z | |
dc.date.issued | 2014-09 | |
dc.description.abstract | Lobate GM Neo, 15 mg is a triple drug combination of a steroid clobetasol with anti-fungal miconazole and antibacterial neomycin in treatment of Eczematous disorders associated with underlying Tinea or Yeast Infections. Aims and Objectives: The study was designed to evaluate the efficacy, safety and tolerability of a combinations of clobetasol, neomycin and miconazole (Group A) versus betamethasone, clotrimazole, neomycin (Group B) versus betamethasone, gentamicin, miconazole (Group C) in subjects with any type of eczematous disorder associated with underlying tinea or yeast infection. Materials and Methods: This was an open label, parallel group, randomized comparative study. The primary endpoint analyzed was improvement in clinical score from baseline at the end of day 7 and other primary endpoint like hyperpigmentation were analyzed by the visual analogue scale of 1 to 10 at the end of day 7. Results: Thirty-six subjects were randomized to three groups. The clinical score showed a significant reduction from baseline at the end of day 7 in all the groups, i.e. 82.9%, 81.3% and 85.6% in Group A, B and C respectively. However, the difference between the groups were not statistically significant. Mean hyper pigmentation score showed significant decrease of 82.9% in Group A, 81.6% in Group B and 92.2% in Group C from baseline at the end of day 7. Conclusion: The triple combination of antifungal, antibacterial and potent steroid was found to be efficacious, safe and tolerable in reducing signs and symptoms (scaling, inflammation, burning and itching) of eczematous disorder associated with underlying tinea/yeast infection. | en_US |
dc.identifier.citation | Shroff Hasmukh Jayantilal. Evaluation of Efficacy, Safety and Tolerability of a Combination of Clobetasol, Neomycin and Miconazole Versus Betamethasone, Clotrimazole and Neomycin Versus Betamethasone, Gentamycin and Miconazole in Subjects with Eczematous Disorders Associated with underlying Tinea or Yeast Infections. Indian Medical Gazette. 2014 Sep ; 148 (9): 325-332. | en_US |
dc.identifier.uri | https://imsear.searo.who.int/handle/123456789/157655 | |
dc.language.iso | en | en_US |
dc.source.uri | https://medind.nic.in/ice/t14/i9/icet14i9p325.pdf | en_US |
dc.subject | eczema | en_US |
dc.subject | tinea | en_US |
dc.subject | clobetasol | en_US |
dc.subject | neomycin | en_US |
dc.subject | miconazole | en_US |
dc.subject.mesh | Adult | |
dc.subject.mesh | Antifungal Agents --administration & dosage | |
dc.subject.mesh | Betamethasone --administration & dosage | |
dc.subject.mesh | Clobetasol --administration & dosage | |
dc.subject.mesh | Clotrimazole --administration & dosage | |
dc.subject.mesh | Drug Combinations | |
dc.subject.mesh | Gentamicins --administration & dosage | |
dc.subject.mesh | Humans | |
dc.subject.mesh | Male | |
dc.subject.mesh | Miconazole --administration & dosage | |
dc.subject.mesh | Mycoses --drug therapy | |
dc.subject.mesh | Neomycin --administration & dosage | |
dc.subject.mesh | Tinea --drug therapy | |
dc.title | Evaluation of Efficacy, Safety and Tolerability of a Combination of Clobetasol, Neomycin and Miconazole Versus Betamethasone, Clotrimazole and Neomycin Versus Betamethasone, Gentamycin and Miconazole in Subjects with Eczematous Disorders Associated with underlying Tinea or Yeast Infections. | en_US |
dc.type | Article | en_US |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- img2014v148n9p325.pdf
- Size:
- 87.25 KB
- Format:
- Adobe Portable Document Format
- Description:
- comparative study
License bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- license.txt
- Size:
- 1.71 KB
- Format:
- Item-specific license agreed upon to submission
- Description: